# iShares Neuroscience and Healthcare ETF

iShares Neuroscience and Healthcare ETF is a ETF series of iShares Trust (series S000076483). Net assets $5.2M as of 2026-04-30. Index fund.

## Profile

- Series ID: S000076483
- Registrant: iShares Trust
- LEI: 549300JGI839T0141L50
- Net assets: $5.2M
- Total assets: $5.6M
- As of: 2026-04-30
- Type: ETF, Index

## Advisers

- [BlackRock Fund Advisors (Advisor)](https://search.stillhousedata.com/firm/105247)

## Top holdings (84 reported)

_Showing 15 of 84 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares](https://search.stillhousedata.com/security/066922519) | — | $444K | 857.13% |
| [Xenon Pharmaceuticals Inc](https://search.stillhousedata.com/security/98420N105) | — | $248K | 478.59% |
| [AXSOME THERAPEUTICS, INC.](https://search.stillhousedata.com/security/05464T104) | — | $238K | 459.31% |
| [ARROWHEAD PHARMACEUTICALS, INC.](https://search.stillhousedata.com/security/04280A100) | — | $228K | 440.65% |
| [ALKERMES PUBLIC LIMITED COMPANY](https://search.stillhousedata.com/security/G01767105) | — | $217K | 419.94% |
| [CENTESSA PHARMACEUTICALS PLC](https://search.stillhousedata.com/security/152309100) | — | $204K | 395.08% |
| [argenx SE](https://search.stillhousedata.com/security/04016X101) | — | $201K | 388.26% |
| [PTC THERAPEUTICS, INC.](https://search.stillhousedata.com/security/69366J200) | — | $191K | 369.41% |
| [NEUROCRINE BIOSCIENCES, INC.](https://search.stillhousedata.com/security/64125C109) | — | $191K | 368.47% |
| [BIOGEN INC.](https://search.stillhousedata.com/security/09062X103) | — | $190K | 367.27% |
| [Scholar Rock Holding Corp](https://search.stillhousedata.com/security/80706P103) | — | $190K | 367.07% |
| [Praxis Precision Medicines Inc](https://search.stillhousedata.com/security/74006W207) | — | $189K | 366.00% |
| [ACADIA PHARMACEUTICALS INC.](https://search.stillhousedata.com/security/004225108) | — | $187K | 361.33% |
| [Dianthus Therapeutics Inc](https://search.stillhousedata.com/security/252828108) | — | $175K | 339.02% |
| [CATALYST PHARMACEUTICALS, INC.](https://search.stillhousedata.com/security/14888U101) | — | $170K | 328.79% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-04-30 | $5.2M |
| 2026-01-31 | $4.9M |
| 2025-10-31 | $4.5M |
| 2025-07-31 | $3.5M |
| 2025-04-30 | $3.4M |
| 2025-01-31 | $3.9M |
| 2024-10-31 | $4.0M |
| 2024-07-31 | $3.9M |

## More

- [Registrant: iShares Trust](https://search.stillhousedata.com/registrant/1100663)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000076483.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.